Atlas Trials

Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO

Clinical trial NCT02149329 · COMPLETED

Trial details

NCT number
NCT02149329
Sponsor
Amsterdam UMC, location VUmc
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Febrile NeutropeniaHematological Malignancy
Start date
2014-12-01
Primary completion
2019-08-05
Enrollment
276

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.